Structure Therapeutics Inc.
GPCRNASDAQHealthcare● Active
$37.77
+$0.19(+0.51%)
Market Cap$2.2B
P/E Ratio—
52W High$94.9
52W Low$15.8
Structure Therapeutics Inc.（GPCR）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · GPCR · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.14B) | ($0.12B) | ($0.09B) | ($0.05B) | ($0.04B) |
| Depreciation & Amort. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.03B | $0.02B | $0.01B | $0.00B | $0.00B |
| Change in Working Capital | ($0.09B) | $0.00B | $0.01B | $0.00B | $0.00B |
| Net Cash from Operations | ($0.22B) | ($0.12B) | ($0.08B) | ($0.05B) | ($0.03B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | ($0.55B) | ($0.70B) | ($0.42B) | ($0.12B) | ($0.00B) |
| Sales of Investments | $0.63B | $0.34B | $0.15B | $0.06B | $0.02B |
| Net Cash from Investing | $0.09B | ($0.36B) | ($0.27B) | ($0.06B) | $0.02B |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | $0.76B | $0.52B | $0.45B | $0.03B | $0.10B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.23B) | ($0.12B) | ($0.08B) | ($0.05B) | ($0.03B) |
| FCF Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Structure Therapeutics Inc.
关于Structure Therapeutics Inc.（GPCR）现金流量表
Structure Therapeutics Inc. 2025财年经营活动现金流($0.22B)，自由现金流($0.23B)（FCF利润率—），资本支出($0.00B)。
常见问题
GPCR · 4 问Structure Therapeutics Inc. 2025财年自由现金流($0.23B)，同比down91.5%。
GPCR free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10